Veloso, Carlos Eduardo <br/><br/>
CFH Y402H polymorphism and response to intravitreal ranibizumab in Brazilian patients with neovascular age-related macular degeneration.  [electronic resource] 

 -  Revista do Colegio Brasileiro de Cirurgioes   
 - 386-92 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1809-4546 
<br/><br/><label>Standard No.: </label>10.1590/0100-69912014006002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--administration & dosage<br/>Brazil<br/>Complement Factor H--genetics<br/>Female<br/>Humans<br/>Intravitreal Injections<br/>Male<br/>Middle Aged<br/>Polymorphism, Single Nucleotide<br/>Ranibizumab--administration & dosage<br/>Retrospective Studies<br/>Treatment Outcome<br/>Wet Macular Degeneration--drug therapy